Medpace Holdings, Inc.

Historical 13F Holders

Symbol
MEDP
CUSIP
58506Q109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 58506Q109 since 12/18/2024, largest first.

Filer % of Class Filed
August J. Troendle 13D/A
19.1% 9/28/2026
Event 9/24/2026
Price T Rowe Associates Inc /MD/ 13G 7.2% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 104 891 k $553 M
2026 Q2 717 38.7 M $13.1 B
2026 Q1 751 24.1 M $11.6 B
2025 Q4 807 23.9 M $13.4 B
2025 Q3 696 24.2 M $12.4 B
2025 Q2 623 26.8 M $8.43 B
2025 Q1 604 25.6 M $7.80 B
2024 Q4 607 25.4 M $8.42 B
2024 Q3 603 25.6 M $8.55 B
2024 Q2 646 26.0 M $10.6 B
2024 Q1 623 26.3 M $10.6 B
2023 Q4 565 25.5 M $7.81 B
2023 Q3 507 24.1 M $5.84 B
2023 Q2 479 24.2 M $5.77 B
2023 Q1 434 25.3 M $4.69 B
2022 Q4 445 25.3 M $5.37 B
2022 Q3 372 26.0 M $4.09 B
2022 Q2 354 26.8 M $4.02 B
2022 Q1 366 27.4 M $4.48 B
2021 Q4 402 29.0 M $6.30 B
2021 Q3 352 28.6 M $5.42 B
2021 Q2 340 27.6 M $4.89 B
2021 Q1 336 28.1 M $4.60 B
2020 Q4 338 28.4 M $3.95 B
2020 Q3 326 27.3 M $3.05 B
2020 Q2 296 28.6 M $2.67 B
2020 Q1 288 28.9 M $2.12 B
2019 Q4 267 29.4 M $2.47 B
2019 Q3 288 28.9 M $2.42 B
2019 Q2 248 30.5 M $1.97 B
2019 Q1 246 27.9 M $1.64 B
2018 Q4 229 30.0 M $1.58 B
2018 Q3 220 25.7 M $1.54 B
2018 Q2 148 14.3 M $616 M
2018 Q1 117 9.62 M $336 M
2017 Q4 115 8.59 M $312 M
2017 Q3 87 6.40 M $204 M
2017 Q2 82 6.31 M $183 M
2017 Q1 78 6.63 M $198 M
2016 Q4 80 7.33 M $264 M
2016 Q3 68 6.17 M $184 M